94870 ⎘
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Sub-classes:CHEMICAL COMPOUNDS AND USES THEREOF
#2USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#3NOVEL CANNABINOID DERIVATIVES
#4INITIATOR, QUANTUM DOT LIGHT-EMITTING LAYER AND MANUFACTURING METHOD THEREOF, LIGHT-EMITTING DEVICE, DISPLAY DEVICE
#5BENZAMIDE COMPOUNDS
#6COMPOUNDS AND COMPOSITIONS FOR NEMATODE TREATMENT
#7COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING
#8MULTIFUNCTIONAL CYTOPROTECTANT FOR TREATMENT OF PATHOGENIC PROCESSES MEDIATED BY OXIDATIVE STRESS AND TOXIC ELECTROPHILES
#9COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
#10SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX
#11Benzamide compounds
#12Compounds and compositions for nematode treatment
#13Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
#14Compounds as modulators of TLR2 signaling
#15Benzamide compounds
#16USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#17Benzamide compounds
#18Benzamide compounds
#19Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
#20Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles
#21SHIP1 modulators and methods related thereto
#22USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)- KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#23IRE-1alpha INHIBITORS
#24Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists
#25Methods and compositions related to retinoid receptor-selective pathway
#26O-phenyl chalcone compounds and uses thereof
#27CHALCONE-UREA DERIVATIVES AS INSULIN SENSORS
#28IRE-1alpha inhibitors
#29Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#30SHIP1 modulators and methods related thereto
#31Onium salt compound, resist composition, and pattern forming process
#32Functionalized naphthalene fluorophores
#33Synthesis, structure and use of functionalized naphthalenes
#34SHIP1 MODULATORS AND METHODS RELATED THERETO
#35Methods and compositions related to a retinoid receptor-selective pathway
#36Treatment of cancer, inflammatory disease, and autoimmune disease
#37Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain
#38Chemical probe compounds that become fluorescent upon reduction, and methods for their use
#39RADIOLABELED 5-HT6 LIGANDS
#40Phenoxy acetic acids and phenyl propionic acids as PPARδ agonists
#41Functionalized naphthalene fluorophores
#42Synthesis, structure and use of functionalized naphthalenes
#43Arylsulfonamide based matrix metalloprotease inhibitors
#44IRE-1α inhibitors
#45Arylsulfonamide based matrix metalloprotease inhibitors
#46DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS
#47Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#48COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR TREATING CANCER
#491,5-diphenyl-penta-1,4-dien-3-one compounds
#50Phenyl propionic acids as PPAR delta activators
#51Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#52Chemical probe compounds that become fluorescent upon reduction, and methods for their use
#53Bicyclic-substituted amines as histamine-3 receptor ligands
#54Therapeutic agent for Alzheimer's disease
#55Class of histone deacetylase inhibitors
#56Arylsulfonamide-based matrix metalloprotease inhibitors
#57Amide derivatives as positive allosteric modulators and methods of use thereof
#58Histone deacetylases inhibitors
#59NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
#60Method for preparing ortho-substituted aminoferrocenes
#61CLASS OF HISTONE DEACETYLASE INHIBITORS
#62SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS
#63NON-IMIDAZOLE ARYLOXYALKYLAMINES
#64Phenylpentadienoyl derivatives and their use as PAR 1 antagonists
#65Carbonylated (aza) cyclohexanes as dopamine Dreceptor ligands
#66Novel Aryl- and Heteroarylpiperazines
#67Amide derivatives as positive allosteric modulators and methods of use thereof
#68Compounds, their preparation and use
#69Substituted phenanthrene diketo acids and uses therefor
#70Bicyclic-substituted amines as histamine-3 receptor ligands
#71NON-IMIDAZOLE ARYLOXYALKYLAMINES
#72Bisbenzamidines for the Treatment of Pneumonia
#73Arylsulfones and uses related thereto
#74CHEMICAL PROBE COMPOUNDS THAT BECOME FLUORESCENT UPON REDUCTION, AND METHODS FOR THEIR USE
#75Phenylalkynes
#76Histone deacetylases inhibitors
#77Phenylalkynes
#78Materials and methods to potentiate cancer treatment
#79New Process for the Synthesis of Morpholinylbenzenes
#80Piperazino based photoinitiators
#81Ligands for metals and improved metal-catalyzed processes based thereon
#82Quaternary Amino-Function Chalcones
#83Modulators of peroxisome proliferator activated receptors
#84Photosensitive resin composition
#85Photosensitive resin composition
#86Piperazino sensitisers
#87Photoinitiators
#88Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
#89Diuretic and diuretic-like compound analogs
#90Phenylalkynes
#91Piperazine-based sensitisers
#92Phenylalkynes
#93Diamino-functional chalcones
#94Non-imidazole aryloxyalkylamines
#95Chemical probe compounds that become fluorescent upon reduction, and methods for their use
#96Bicyclic-substituted amines as histamine-3 receptor ligands
#97Modulators of dopamine neurotransmission
#98Fused benzene derivative and use
#99Storage stability of photoinitiators
#100Ligands for metals and improved metal-catalyzed processes based thereon
#101Amino-functional chalcones
#102Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
#103Arylsulfones and uses related thereto
#1041-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands
#105Aminoalkoxy-functional chalcones
#106Non-imidazole aryloxypiperidines
#107Substituted n-aryl amidines as selective D dopamine receptor antagonists for the treatment of obesity and CNS disorders
#108Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#109Naphthalene derivatives
#110Diamine derivatives of quinone and uses thereof
#111Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
#112Modulators of peroxisome proliferator activated receptors
#113Process for the synthesis of morpholinylbenzenes
#114Benzamide compounds